Loading insider details...
Latest Form 4 (Nov 4, 2026): Sale of 5,000 XERS shares, $51.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 5,000 | $51.2K |
| Oct 2, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 5,000 | $47.0K |
| Sep 1, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 5,000 | $42.5K |
| Aug 12, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 5,000 | $42.5K |
| Jul 7, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 17,400 | $147.9K |
| Mar 6, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Exercise/Conversion | 27,891 | $114.1K |
| Feb 2, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/Award | 154,986 | n/a |
| Feb 4, 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Tax Withholding | 110,750 | $394.3K |
| Jan 7, 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Tax Withholding | 32,059 | $115.7K |
| Nov 26, 2024 | Xeris Biopharma Holdings, Inc. (XERS) | Exercise/Conversion | 19,483 | $30.2K |